News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McClung David Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| McClung David Mark (EVP, COO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,925 shares
@ $1.33, valued at
$2.6k
|
|
| 03/06/2023 |
4
| McClung David Mark (EVP, COO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 56,250 shares
@ $0
Paid exercise price by delivering 9,745 shares
@ $2.66, valued at
$25.9k
Granted 262,500 options to buy
@ $2.66, valued at
$698.3k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| McClung David Mark (EVP, Chief Business Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 11,525 shares
@ $12.02, valued at
$138.5k
|
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
3
| McClung David Mark (EVP Chief Business Officer) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
|
|